These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22544005)

  • 61. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
    Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
    Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Risperidone But Not Quetiapine Treatment Is Associated With Increased Appetite But Not Satiety Hormones in Children During An Oral Glucose Tolerance Test: A Pilot Study.
    Ngai YF; Devlin AM; Panagiotopoulos C
    J Clin Psychopharmacol; 2018 Dec; 38(6):622-626. PubMed ID: 30300290
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.
    Melkersson KI; Hulting AL; Brismar KE
    J Clin Psychiatry; 2000 Oct; 61(10):742-9. PubMed ID: 11078035
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Second-generation antipsychotics and adiponectin levels in schizophrenia: A comparative meta-analysis.
    Bartoli F; Crocamo C; Clerici M; Carrà G
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1767-74. PubMed ID: 26164075
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Do prior authorization policies discourage first-line antipsychotic use in patients newly discharged from a hospitalization for schizophrenia in Saskatchewan?
    Blackburn DF; Tran D; Crawley A; Lynds S; Champagne A; Bresee L; Remillard AJ
    J Popul Ther Clin Pharmacol; 2014; 21(1):e31-7. PubMed ID: 24615368
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychotics.
    Cuerda C; Merchan-Naranjo J; Velasco C; Gutierrez A; Leiva M; de Castro MJ; Parellada M; Giráldez M; Bretón I; Camblor M; García-Peris P; Dulín E; Sanz I; Desco M; Arango C
    Clin Nutr; 2011 Oct; 30(5):616-23. PubMed ID: 21492975
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metabolic risk factors in schizophrenia and bipolar disorder: The effect of comedication with selective serotonin reuptake inhibitors and antipsychotics.
    Fjukstad KK; Engum A; Lydersen S; Dieset I; Steen NE; Andreassen OA; Spigset O
    Eur Psychiatry; 2018 Feb; 48():71-78. PubMed ID: 29331603
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The early effect of olanzapine and risperidone on insulin secretion in atypical-naïve schizophrenic patients.
    Chiu CC; Chen KP; Liu HC; Lu ML
    J Clin Psychopharmacol; 2006 Oct; 26(5):504-7. PubMed ID: 16974193
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia.
    Lin Y; Peng Y; He S; Xu J; Shi Y; Su Y; Zhu C; Zhang X; Zhou R; Cui D
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):71-78. PubMed ID: 29410009
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with schizophrenia.
    Richards AA; Hickman IJ; Wang AY; Jones AL; Newell F; Mowry BJ; Whitehead JP; Prins JB; Macdonald GA
    J Clin Psychopharmacol; 2006 Jun; 26(3):232-7. PubMed ID: 16702887
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: findings from a Veterans Affairs-based population.
    Hsu C; Ried LD; Bengtson MA; Garman PM; McConkey JR; Rahnavard F
    J Am Pharm Assoc (2003); 2008; 48(3):393-400. PubMed ID: 18595825
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of risperidone on leptin and insulin in children and adolescents with autistic spectrum disorders.
    Srisawasdi P; Vanwong N; Hongkaew Y; Puangpetch A; Vanavanan S; Intachak B; Ngamsamut N; Limsila P; Sukasem C; Kroll MH
    Clin Biochem; 2017 Aug; 50(12):678-685. PubMed ID: 28167244
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Increased Risk of Obesity and Metabolic Dysregulation Following 12 Months of Second-Generation Antipsychotic Treatment in Children: A Prospective Cohort Study.
    Ronsley R; Nguyen D; Davidson J; Panagiotopoulos C
    Can J Psychiatry; 2015 Oct; 60(10):441-50. PubMed ID: 26720191
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: a meta-analysis.
    Bartoli F; Lax A; Crocamo C; Clerici M; Carrà G
    Psychoneuroendocrinology; 2015 Jun; 56():179-89. PubMed ID: 25827962
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of fasting blood sugar and serum lipid profile changes after treatment with atypical antipsychotics olanzapine and risperidone.
    Kaushal J; Bhutani G; Gupta R
    Singapore Med J; 2012 Jul; 53(7):488-92. PubMed ID: 22815019
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The time-dependent change of insulin secretion in schizophrenic patients treated with olanzapine.
    Chiu CC; Chen CH; Chen BY; Yu SH; Lu ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):866-70. PubMed ID: 20394794
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Glucose dysregulation among veterans living with schizophrenia-related disorders after switching second-generation antipsychotics.
    Ried LD; Brumback B; Bengtson MA; Garman PM; Hsu C; McConkey JR
    J Am Pharm Assoc (2003); 2009; 49(2):223-31. PubMed ID: 19289350
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot study.
    Togo T; Kojima K; Shoji M; Kase A; Uchikado H; Katsuse O; Iseki E; Kosaka K
    Int Clin Psychopharmacol; 2004 Jan; 19(1):37-40. PubMed ID: 15101569
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Assessment of Irisin, Adiponectin and Leptin Levels in Patients with Schizophrenia.
    Erzin G; Topcuoglu C; Kotan VO; Bayram S; Fountoulakis K
    Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):163-169. PubMed ID: 29219062
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adiposity-independent hypoadiponectinemia as a potential marker of insulin resistance and inflammation in schizophrenia patients treated with second generation antipsychotics.
    Sapra M; Lawson D; Iranmanesh A; Varma A
    Schizophr Res; 2016 Jul; 174(1-3):132-136. PubMed ID: 27211515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.